Revvity (RVTY) Capital Expenditures Growth (3y) (2012 - 2026)

Revvity (RVTY) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn -
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn -6.36%
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn -3.77%
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn -12.74%
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn 10.06%
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn 24.83%
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn -8.17%
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn -9.93%
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn -9.11%
10 Revvity 11.63 Bn 10.77 Bn 387.66 Mn -1.90%

Historic Data

Download Data
DateValue
Apr 5, 2026 -1.90%
Dec 28, 2025 -8.77%
Mar 30, 2025 -16.00%
Sep 29, 2024 -2.92%
Jun 30, 2024 2.66%
Mar 31, 2024 7.63%
Dec 31, 2023 56.91%
Oct 1, 2023 3.35%
Jul 2, 2023 -5.73%
Apr 2, 2023 0.74%
Jan 1, 2023 4.55%
Apr 3, 2022 10.71%
Oct 3, 2021 5.39%
Jul 4, 2021 6.30%
Apr 4, 2021 -14.19%
Jan 3, 2021 -28.00%
Oct 4, 2020 22.98%
Jul 5, 2020 44.73%
Apr 5, 2020 50.74%
Dec 29, 2019 18.74%